Followers | 134 |
Posts | 7040 |
Boards Moderated | 0 |
Alias Born | 02/09/2012 |
Thursday, October 29, 2020 9:38:25 PM
YOU QUESTION: "How is the (longs) TRUST LEVEL SO HIGH...?"
EASY ANSWER: SUCCESS and POSITIVE FACTS DO NOT LIE.!!!
Below...ALL FACTS!
October 2, 2020
INNOVATION PHARMACEUTICALS ANNOUNCES PRE-IND MEETING REQUEST GRANTED BY FDA FOR THE STUDY OF BRILACIDIN FOR THE TREATMENT OF COVID-19
September 15, 2020
LABORATORY TESTING OF BRILACIDIN FOR COVID-19 IN COMBINATION WITH REMDESIVIR REDUCES VIRAL LOAD BY NEARLY 100 PERCENT
August 26, 2020DR.
WILLIAM F. DEGRADO, A DISCOVERER OF BRILACIDIN, JOINS INNOVATION PHARMACEUTICALS AS SCIENTIFIC ADVISOR
August 24, 2020
COVID-19 DRUG CANDIDATE BRILACIDIN ACHIEVES A SELECTIVITY INDEX AMONG THE HIGHEST REPORTED, EXHIBITING POTENT ANTI-SARS-COV-2 ACTIVITY AT LOW CONCENTRATIONS; CLINICAL TRIAL FORTHCOMING
August 4, 2020
INNOVATION PHARMACEUTICALS AND U.S. REGIONAL BIOCONTAINMENT LABORATORY NEARING COMPLETION OF BRILACIDIN ANTI-SARS-COV-2 (COVID-19) IN VITRO TESTING
July 20, 2020
INNOVATION PHARMACEUTICALS’ BRILACIDIN INHIBITS NOVEL CORONAVIRUS (COVID-19) BY ALMOST 90% AT THE LOWEST CONCENTRATION TESTED TO DATE IN A HUMAN LUNG CELL LINE
July 13, 2020
INNOVATION PHARMACEUTICALS – CLINICAL TRIAL TESTING OF BRILACIDIN AGAINST SARS-COV-2 (COVID-19) TARGETED TO COMMENCE Q4 2020
July 7, 2020
IN VITRO TESTING OF INNOVATION PHARMACEUTICALS’ BRILACIDIN FOR COVID-19 SHOWS CONSISTENT ANTI-SARS-COV-2 EFFICACY; MANUFACTURING PREPARATION UNDERWAY FOR COVID-19 CLINICAL TRIAL
June 17, 2020
INNOVATION PHARMACEUTICALS’ BRILACIDIN INHIBITS SARS-COV-2 (COVID-19) BY 97 PERCENT IN A HUMAN LUNG CELL LINE
June 11, 2020
INNOVATION PHARMACEUTICALS COLLABORATING WITH REGIONAL BIOCONTAINMENT LAB ON GRANT APPLICATION TO RESEARCH BRILACIDIN AS A PAN-CORONAVIRUS THERAPEUTIC
May 26, 2020
INNOVATION PHARMACEUTICALS RECEIVES DATA FROM PUBLIC HEALTH RESEARCH INSTITUTE SHOWING BRILACIDIN INHIBITS SARS-COV-2 (COVID-19) IN A HUMAN CELL LINE
May 19, 2020
INNOVATION PHARMACEUTICALS’ BRILACIDIN REDUCES VIRAL TITER OF SARS-COV-2 (COVID-19) BY 75 PERCENT AFTER ONLY 1 HOUR OF PREINCUBATION IN IN VITRO STUDY AT BSL-3 FACILITY
May 5, 2020
INHIBITORY EFFECT OF INNOVATION PHARMACEUTICALS’ BRILACIDIN ON SARS-COV-2 (COVID-19) IN PRIMARY HUMAN IMMUNE CELLS TO BE STUDIED AT LEADING PUBLIC HEALTH RESEARCH INSTITUTE
April 27, 2020
INNOVATION PHARMACEUTICALS INFORMED NEXT PHASE OF BRILACIDIN CORONAVIRUS (COVID-19) TESTING TO BEGIN WEEK OF MAY 4
April 6, 2020
INNOVATION PHARMACEUTICALS IN DISCUSSIONS TO ADVANCE BRILACIDIN INTO HUMAN TRIALS AGAINST COVID-19
April 1, 2020
INNOVATION PHARMACEUTICALS RECEIVES DATA SUPPORTING BRILACIDIN’S DIRECT INHIBITION OF SARS-COV-2, THE NOVEL CORONAVIRUS RESPONSIBLE FOR COVID-19
March 17, 2020
INNOVATION PHARMACEUTICALS BRILACIDIN TO BE RESEARCHED AS POSSIBLE NOVEL CORONAVIRUS (COVID-19) VACCINE; BRILACIDIN NOW BEING TESTED AS DRUG AND VACCINE AT DIFFERENT INSTITUTIONS
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM